Microbiota Restoration Therapy (RBX2660)

RBX2660 · Rebiotix Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Microbiota Restoration Therapy (RBX2660), covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) [Phase 3]